Status:
COMPLETED
Inflammatory Response to Opioid Versus Opioid Free Anesthesia
Lead Sponsor:
University of Guadalajara
Conditions:
Morbid Obesity
Opioid Use
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Anesthetic agents, including opioids can modulate the altered immune function in patients with obesity through mechanisms that involve the expression and release of cytokines. For this reason, anesthe...
Eligibility Criteria
Inclusion
- Who were scheduled for bypass surgery at the Service of Anesthesiology and Bariatric Surgery of the Civil Hospital of Guadalajara "Dr. Juan I Menchaca", Jalisco, Mexico, were recruited.
Exclusion
- Patients with a history of ischemic heart disease, history of drug abuse, and with any known allergy to any of the drugs used during anesthesia. Elimination criteria were: patients who withdrew their consent or with insufficient and poor quality blood samples (coagulated) or other reasons that did not allow sample processing.
Key Trial Info
Start Date :
November 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04854252
Start Date
November 12 2020
End Date
March 29 2021
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erika Martínez-López
Guadalajara, Jalisco, Mexico, 44340